932 related articles for article (PubMed ID: 25622193)
1. Innate immune recognition of cancer.
Woo SR; Corrales L; Gajewski TF
Annu Rev Immunol; 2015; 33():445-74. PubMed ID: 25622193
[TBL] [Abstract][Full Text] [Related]
2. The host STING pathway at the interface of cancer and immunity.
Corrales L; McWhirter SM; Dubensky TW; Gajewski TF
J Clin Invest; 2016 Jul; 126(7):2404-11. PubMed ID: 27367184
[TBL] [Abstract][Full Text] [Related]
3. Innate immune signaling and regulation in cancer immunotherapy.
Corrales L; Matson V; Flood B; Spranger S; Gajewski TF
Cell Res; 2017 Jan; 27(1):96-108. PubMed ID: 27981969
[TBL] [Abstract][Full Text] [Related]
4. Innate immune sensing of cancer: clues from an identified role for type I IFNs.
Gajewski TF; Fuertes MB; Woo SR
Cancer Immunol Immunother; 2012 Aug; 61(8):1343-7. PubMed ID: 22722449
[TBL] [Abstract][Full Text] [Related]
5. Targeting Cytosolic Nucleic Acid-Sensing Pathways for Cancer Immunotherapies.
Iurescia S; Fioretti D; Rinaldi M
Front Immunol; 2018; 9():711. PubMed ID: 29686682
[TBL] [Abstract][Full Text] [Related]
6. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors.
Woo SR; Fuertes MB; Corrales L; Spranger S; Furdyna MJ; Leung MY; Duggan R; Wang Y; Barber GN; Fitzgerald KA; Alegre ML; Gajewski TF
Immunity; 2014 Nov; 41(5):830-42. PubMed ID: 25517615
[TBL] [Abstract][Full Text] [Related]
7. Innate immune mediators in cancer: between defense and resistance.
Berraondo P; Minute L; Ajona D; Corrales L; Melero I; Pio R
Immunol Rev; 2016 Nov; 274(1):290-306. PubMed ID: 27782320
[TBL] [Abstract][Full Text] [Related]
8. Fast dendritic cells stimulated with alternative maturation mixtures induce polyfunctional and long-lasting activation of innate and adaptive effector cells with tumor-killing capabilities.
Massa C; Seliger B
J Immunol; 2013 Apr; 190(7):3328-37. PubMed ID: 23447683
[TBL] [Abstract][Full Text] [Related]
9. STING pathway agonism as a cancer therapeutic.
Flood BA; Higgs EF; Li S; Luke JJ; Gajewski TF
Immunol Rev; 2019 Jul; 290(1):24-38. PubMed ID: 31355488
[TBL] [Abstract][Full Text] [Related]
10. Synergistic activation of innate immunity by double-stranded RNA and CpG DNA promotes enhanced antitumor activity.
Whitmore MM; DeVeer MJ; Edling A; Oates RK; Simons B; Lindner D; Williams BR
Cancer Res; 2004 Aug; 64(16):5850-60. PubMed ID: 15313929
[TBL] [Abstract][Full Text] [Related]
11. STING, DCs and the link between innate and adaptive tumor immunity.
Vatner RE; Janssen EM
Mol Immunol; 2019 Jun; 110():13-23. PubMed ID: 29273394
[TBL] [Abstract][Full Text] [Related]
12. The 'kiss of death' by dendritic cells to cancer cells.
Chan CW; Housseau F
Cell Death Differ; 2008 Jan; 15(1):58-69. PubMed ID: 17948029
[TBL] [Abstract][Full Text] [Related]
13. Nucleic Acid Sensing Machinery: Targeting Innate Immune System for Cancer Therapy.
Iurescia S; Fioretti D; Rinaldi M
Recent Pat Anticancer Drug Discov; 2018; 13(1):2-17. PubMed ID: 29086701
[TBL] [Abstract][Full Text] [Related]
14. Targeting innate immune pathways in cancer immunotherapy: state of the art.
Mastellos DC
J BUON; 2009 Sep; 14 Suppl 1():S123-30. PubMed ID: 19785054
[TBL] [Abstract][Full Text] [Related]
15. Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies.
Klippstein R; Pozo D
Nanomedicine; 2010 Aug; 6(4):523-9. PubMed ID: 20085824
[TBL] [Abstract][Full Text] [Related]
16. Immunosurveillance and immunotherapy of tumors by innate immune cells.
Iannello A; Thompson TW; Ardolino M; Marcus A; Raulet DH
Curr Opin Immunol; 2016 Feb; 38():52-8. PubMed ID: 26686774
[TBL] [Abstract][Full Text] [Related]
17. Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions.
Willemen Y; Van den Bergh JM; Lion E; Anguille S; Roelandts VA; Van Acker HH; Heynderickx SD; Stein BM; Peeters M; Figdor CG; Van Tendeloo VF; de Vries IJ; Adema GJ; Berneman ZN; Smits EL
Cancer Immunol Immunother; 2015 Jul; 64(7):831-42. PubMed ID: 25863943
[TBL] [Abstract][Full Text] [Related]
18. CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo.
Gonzalez-Carmona MA; Lukacs-Kornek V; Timmerman A; Shabani S; Kornek M; Vogt A; Yildiz Y; Sievers E; Schmidt-Wolf IG; Caselmann WH; Sauerbruch T; Schmitz V
Hepatology; 2008 Jul; 48(1):157-68. PubMed ID: 18537185
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cells and damage-associated molecular patterns: endogenous danger signals linking innate and adaptive immunity.
Nace G; Evankovich J; Eid R; Tsung A
J Innate Immun; 2012; 4(1):6-15. PubMed ID: 22086146
[TBL] [Abstract][Full Text] [Related]
20. STING-mediated DNA sensing in cancer immunotherapy.
Zhou X; Jiang Z
Sci China Life Sci; 2017 Jun; 60(6):563-574. PubMed ID: 28639100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]